Conditions: Metastatic Breast Cancer; Locally Advanced Breast Cancer; Advanced Breast Cancer; BRCA2 Mutation; BRCA1 Mutation
Interventions: Drug: Palbociclib; Drug: Olaparib; Drug: Fulvestrant
Sponsor: Abramson Cancer Center of the University of Pennsylvania
**RECRUITING NOW**
Interventions: Drug: Palbociclib; Drug: Olaparib; Drug: Fulvestrant
Sponsor: Abramson Cancer Center of the University of Pennsylvania
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
